X
Flash FDA approval sends ChemoCentryx spiralling upwards
https://pharmaphorum.com/news/flash-fda-approval-sends-chemocentryx-spiralling-upwards/
autoimmune disease
Genentech’s Rituxan approved for rare skin disease
The FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years.